CR10430A - Aminothiazoles and their uses - Google Patents

Aminothiazoles and their uses

Info

Publication number
CR10430A
CR10430A CR10430A CR10430A CR10430A CR 10430 A CR10430 A CR 10430A CR 10430 A CR10430 A CR 10430A CR 10430 A CR10430 A CR 10430A CR 10430 A CR10430 A CR 10430A
Authority
CR
Costa Rica
Prior art keywords
aminothiazoles
Prior art date
Application number
CR10430A
Other languages
English (en)
Inventor
Matthew J Lamarche
Simon Bushell
Michael A Patane
Lewis Whitehead
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38645676&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR10430(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CR10430A publication Critical patent/CR10430A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
CR10430A 2006-05-31 2008-11-10 Aminothiazoles and their uses CR10430A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80969306P 2006-05-31 2006-05-31

Publications (1)

Publication Number Publication Date
CR10430A true CR10430A (es) 2009-01-15

Family

ID=38645676

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10430A CR10430A (es) 2006-05-31 2008-11-10 Aminothiazoles and their uses

Country Status (32)

Country Link
US (2) US7851439B2 (es)
EP (2) EP2044101B1 (es)
JP (1) JP5351014B2 (es)
KR (1) KR101061658B1 (es)
CN (2) CN101454337A (es)
AR (1) AR060977A1 (es)
AU (1) AU2007255025B2 (es)
BR (1) BRPI0711885A2 (es)
CA (1) CA2650133A1 (es)
CL (1) CL2007001542A1 (es)
CR (1) CR10430A (es)
DK (1) DK2044101T3 (es)
EC (1) ECSP088922A (es)
ES (1) ES2441993T3 (es)
HK (1) HK1127614A1 (es)
HR (1) HRP20140055T1 (es)
IL (1) IL194880A (es)
MA (1) MA30485B1 (es)
MX (1) MX2008015216A (es)
MY (1) MY146920A (es)
NO (1) NO20085032L (es)
NZ (1) NZ572154A (es)
PE (2) PE20121011A1 (es)
PL (1) PL2044101T3 (es)
PT (1) PT2044101E (es)
RU (1) RU2450015C2 (es)
SI (1) SI2044101T1 (es)
TN (1) TNSN08496A1 (es)
TW (2) TW201107337A (es)
UA (1) UA95627C2 (es)
WO (1) WO2007142986A2 (es)
ZA (1) ZA200808449B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20121011A1 (es) * 2006-05-31 2012-08-25 Novartis Ag AMINOTIAZOLES COMO MODULADORES DEL FACTOR DE ELONGACION EF-Tu
US8183341B2 (en) 2006-12-20 2012-05-22 Novartis Ag Antibacterial compounds and processes for its production
EP2170907A2 (en) * 2007-06-04 2010-04-07 Novartis Ag Macrocycles and their uses
EP2229386B1 (en) * 2007-12-12 2015-06-03 Novartis AG An aminothiazole derivative as antibacterial agent
AU2012261611B2 (en) * 2007-12-12 2014-05-15 Novartis Ag Aminothiazoles and their uses
WO2014167371A1 (en) * 2013-04-12 2014-10-16 Naicons S.C.A.R.L. Analogs of the antibiotic aminothiazole ge2270
CN106366168B (zh) * 2016-08-26 2020-09-15 上海交通大学 羊毛硫肽类抗菌肽及其脱氢衍生物的制备方法
CN107243008B (zh) * 2017-04-13 2021-03-30 中国科学院广州生物医药与健康研究院 吡唑并[1,5-a]吡啶类化合物的新应用及一种治疗脓肿分枝杆菌感染的组合物
CN113219078B (zh) * 2021-03-25 2022-12-16 广东产品质量监督检验研究院（国家质量技术监督局广州电气安全检验所、广东省试验认证研究院、华安实验室） 一种生活用纸制品中17种有机抗菌剂快速筛查方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202241A (en) 1988-09-09 1993-04-13 Gruppo Lepetit S.P.A. Antibiotic GE 2270
US5139778A (en) 1989-07-04 1992-08-18 Gruppo Lepetit Spa Antibiotic ge 2270 factors a1, a2, a3 and h
DE69108972T2 (de) 1990-03-08 1995-10-19 Lepetit Spa Antibiotika GE 2270 Faktoren B1, B2, C1, D1, D2, E und T.
IL100572A (en) 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
DK0529410T3 (da) 1991-08-30 1998-05-11 Biosearch Italia Spa Antibiotikum GE 2270 faktor C2a
US5882900A (en) * 1992-09-10 1999-03-16 Gruppo Lepetit S.P.A. Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium
WO1994014838A1 (en) 1992-12-22 1994-07-07 Gruppo Lepetit S.P.A. Antibiotics ge 37468 a, b and c
JPH10508476A (ja) * 1994-11-08 1998-08-25 グルポ・レペチツト・エス・ピー・エイ 抗生物質ｇｅ２２７０因子ｄ▲下２▼を得るための微生物変換法
KR100381688B1 (ko) 1995-02-07 2003-12-11 바이오써치 이탈리아 에스.피.에이. Ge2270및ge2270-유사항생제의염기성프롤린-아미드유도체
ATE205505T1 (de) 1995-02-07 2001-09-15 Biosearch Italia Spa Basische oxazolinamid-derivate von ge2270 und ge2270-änlichen antibiotika
AU714958B2 (en) * 1996-02-14 2000-01-13 Vicuron Pharmaceuticals Inc. Derivatives of antibiotic GE2270 factors C2a D2 and E
JPH1059997A (ja) * 1996-08-22 1998-03-03 Microbial Chem Res Found アミチアマイシンアミド誘導体
JP4723857B2 (ja) * 2002-06-17 2011-07-13 ヴィキュロン ファーマシューティカルズ インコーポレイテッド アクネの治療のためのｇｅ２２７０因子ａ３のアミド誘導体の使用
AU2005327139A1 (en) 2004-09-22 2006-08-17 Merck & Co., Inc. Antibiotic compound
PE20121011A1 (es) 2006-05-31 2012-08-25 Novartis Ag AMINOTIAZOLES COMO MODULADORES DEL FACTOR DE ELONGACION EF-Tu
EP2229386B1 (en) * 2007-12-12 2015-06-03 Novartis AG An aminothiazole derivative as antibacterial agent

Also Published As

Publication number Publication date
CL2007001542A1 (es) 2008-03-14
AU2007255025A1 (en) 2007-12-13
RU2008150785A (ru) 2010-07-10
EP2322536A2 (en) 2011-05-18
JP2009538914A (ja) 2009-11-12
US7851439B2 (en) 2010-12-14
EP2322536A3 (en) 2011-11-30
CN102399260B (zh) 2015-04-15
MX2008015216A (es) 2008-12-12
TNSN08496A1 (en) 2010-04-14
WO2007142986A2 (en) 2007-12-13
US20080221142A1 (en) 2008-09-11
SI2044101T1 (sl) 2014-01-31
IL194880A0 (en) 2011-08-01
TW201107337A (en) 2011-03-01
PT2044101E (pt) 2014-01-03
CA2650133A1 (en) 2007-12-13
PE20121011A1 (es) 2012-08-25
HK1127614A1 (en) 2009-10-02
US20100267757A1 (en) 2010-10-21
MY146920A (en) 2012-10-15
RU2450015C2 (ru) 2012-05-10
NZ572154A (en) 2011-12-22
HRP20140055T1 (hr) 2014-02-14
DK2044101T3 (da) 2014-01-13
TW200811189A (en) 2008-03-01
TWI342310B (en) 2011-05-21
CN101454337A (zh) 2009-06-10
KR101061658B1 (ko) 2011-09-01
BRPI0711885A2 (pt) 2012-03-06
PL2044101T3 (pl) 2014-03-31
ECSP088922A (es) 2008-12-30
NO20085032L (no) 2008-12-16
CN102399260A (zh) 2012-04-04
KR20090006869A (ko) 2009-01-15
IL194880A (en) 2015-02-26
EP2044101B1 (en) 2013-10-09
ZA200808449B (en) 2014-12-23
ES2441993T3 (es) 2014-02-07
JP5351014B2 (ja) 2013-11-27
AR060977A1 (es) 2008-07-23
EP2044101A2 (en) 2009-04-08
MA30485B1 (fr) 2009-06-01
AU2007255025B2 (en) 2011-07-14
WO2007142986A3 (en) 2008-04-10
UA95627C2 (ru) 2011-08-25
PE20080103A1 (es) 2008-04-03

Similar Documents

Publication Publication Date Title
BRPI0716300A2 (pt) Artigo e mistura
DE602007012130D1 (de) Modifizierte flavin-adenin-dinucleotid-abhängige glucose-dehydrogenase
DE602007010795D1 (de) Blattsauger und -häcksler
DE602006019782D1 (de) Kapselperforationsmodul
DE602007002544D1 (de) Nuancierungsmittel
DE602007008423D1 (de) Flüssigkeitshärtung
DE602007006947D1 (de) Pyridopyrimidinonderivate
DE602007000258D1 (de) Kassetteneinspannmechanismus
DE602007001280D1 (de) Getränkeextraktor
DE602007003533D1 (de) Karosserierahmenbauteil
AT504580A3 (de) Scan-einrichtung
DE602007008400D1 (de) Kaliummonopersulfatlösungen
DE602006019150D1 (de) Riemenscheibenanorndung
ATE546437T1 (de) Aminomethyl-4-imidazole
DE502007000218D1 (de) nsetzungen
DE502007002453D1 (de) Kunstoffverdichtergehäuse
DE602006016174D1 (de) Blisterverpackungsverfahren
DE602007007460D1 (de) Sehkrafttestsystem
DE602007004080D1 (de) Tintenstrahlaufnehmer
CR10430A (es) Aminothiazoles and their uses
DE502007000361D1 (de) Stanznieteinheit
DE602007005649D1 (de) Lastansteueranordnung
DE602007001098D1 (de) Spindelmäheinheit
DE112007003147A5 (de) Rohr-Biegevorrichtung
DE502007001652D1 (de) Notöltank